Skip to main content
. 2017 Nov 27;39(2):473–482. doi: 10.3892/or.2017.6114

Figure 1.

Figure 1.

Upregulation of miR-133a in breast cancer. (A) Real-time PCR was used to examine the miR-133a levels in breast cancer tissues compared with adjacent non-tumor tissues. (B) Real-time PCR was used to examine the miR-133a levels in breast cancer cell lines compared with normal human breast cell line Hs 578Bst. (C) The breast cancer patients with low miR-133a expression showed shorter survival time compared with those with high miR-133a expression. **P<0.01 vs. Hs 578Bst.